Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCAT | P04180 | 2/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | OGA | O60502 | 1/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23996514 | 0.94 | LCAT (0.35) | LCATCTSBCTSSCTSKKCNH2 | |
| SCHEMBL25420582 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL23996736 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL23996726 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL23996507 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL25420471 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL25420477 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL25420474 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL25420579 | 0.84 | LCAT (0.37) | LCAT | |
| SCHEMBL23996511 | 0.84 | LCAT (0.37) | LCAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021224865-A1 | NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC. (CA) | 2021-11-11 | — | — | WO | disclosed |